The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g)
Top Cited Papers
Open Access
- 1 April 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (4) , 811-816
- https://doi.org/10.1161/01.str.31.4.811
Abstract
Background and Purpose—A number of studies have shown that reduced intrauterine growth and low birth weight are associated with raised rates of fatal and nonfatal stroke in adult life. Whether this increased risk of stroke is modified by growth in childhood or by socioeconomic status in adult life is not known.Keywords
This publication has 4 references indexed in Scilit:
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE: A Practical ScalePublished by Elsevier ,1975